Economic evaluation of trimetazidine in the management of chronic stable angina in Greece
نویسندگان
چکیده
BACKGROUND To evaluate the cost-effectiveness of trimetazidine (TMZ) as add-on therapy to standard-of-care (SoC) compared to SoC alone in patients with chronic stable angina who did not respond adequately to first line therapy with b-blockers, nitrates or calcium channel antagonists in Greece. METHODS A Markov model with 3-month cycles and 1-year time horizon was developed to assess the comparators. The analysis was conducted from a third-party payer perspective. The clinical inputs and utility values were extracted from the published literature. Resource consumption data were obtained from local experts, using a questionnaire developed for the purpose of the study and were combined with unit cost data (in €2016) obtained from official sources. Cost effectiveness was assessed by calculating the incremental cost effectiveness ratio (ICER). Probabilistic sensitivity analysis (PSA) was performed to account for uncertainty and variation in the input parameters of the model. RESULTS The analysis showed that the cost of TMZ plus SoC was €1755.57 versus €1751.76 of SoC alone. In terms of health outcomes, TMZ plus SoC was associated with 0.6650 QALYs versus 0.6562 QALYs for SoC alone. The incremental analysis resulted in an ICER of €430.67 per QALY gained. PSA revealed that the probability of TMZ plus SoC being cost-effective over SoC was 89 %, at a threshold of €34,000 per QALY gained. CONCLUSION The results indicate that TMZ as add -on treatment may be a highly cost-effective option for the symptomatic treatment of patients with chronic stable angina in Greece relative to SoC alone.
منابع مشابه
Regional Clinical Guideline for the Management of Stable Angina
Background and purpose: Prevalence of risk factors for health is growing rapidly in developing countries due to urbanization. In fact much of the global burden of some conditions such as ischemic heart disease is currently in low- and middle-income countries. Therefore, an integrated and effective clinical guide is highly needed for management of patients with stable angina. Materials and meth...
متن کاملبررسی میزان سطح اسید اوریک سرمی و شدت درگیری عروق کرونر در آنژیوگرافی در بیماران مبتلا به chronic Stable Angina
Background and purpose: Coronary artery disease (CAD) is the first cause of death in modern societies. It is also the first cause for individual health care cost. Multiple risk factors are mentioned for its development among which elevated uric acid is recently introduced as an inflammatory factor. This study was performed for evaluating the serum uric acid level and severity of CAD determined...
متن کاملMonocyte Expression of Toll-like Receptor-4 in Patients with Stable Angina Undergoing Percutanoeus Coronary Intervention
Background: Toll like receptors (TLRs) are well recognized players in inflammatory conditions. Among them TLR-4 is involved in chronic inflammatory processes such as formation of atherosclerotic plaques. Objective: The present study was aimed to examine the effects of percutanoeus coronary intervention (PCI) as a revascularization method on monocyte expression of hTLR-4 and on the serum levels ...
متن کاملVastarel MR: from decades of clinical experience in stable angina to new perspectives
Trimetazidine has been known for years as being an effective, ‘‘patient-friendly’’, anti-anginal agent. Recent studies using the modified release formulation (Vastarel MR) have confirmed the efficacy of trimetazidine in stable ischemic heart disease and suggested that it can be beneficial in a number of
متن کاملCombination treatment with trimetazidine and diltiazem in stable angina pectoris.
OBJECTIVE To assess antianginal efficacy and possible adverse haemodynamic effects of combination treatment with trimetazidine and diltiazem in patients with stable angina. DESIGN Double blind, randomised, placebo controlled trial of four weeks duration. SETTING Outpatient department of two Indian hospitals. SUBJECTS 64 male patients with stable angina, uncontrolled on diltiazem alone. ...
متن کامل